Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa
Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa
Recruiting · NCT07482787 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Abnormalities, Skin Manifestations, Skin and Connective Tissue Diseases, epidermolysis bullosa, hereditary disease, hereditary skin disorder, skin disorder, vesiculobullous skin disease | Recruiting | Phase 3 | 2026-09-04 | NCT07482787 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Paradigm Therapeutics | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medical University of South Carolina Department of Dermatology and Dermatologic Surgery | Charleston | United States | 3 |
| Mission Dermatology | Rancho Santa Margarita | United States | 2 |
| Stanford University School of Medicine Dermatology Department | Redwood City | United States | 1 |